長期投資家のためのIR情報
バリュートレンド

【2176】イナリサーチ 〔上場廃止〕
ー(上場廃止)医薬品の非臨床試験。
類似企業:


東証スタンダード
サー
治験
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2023.03 2022/08/10 Q1予 4,328 0.0% 0.0% 373 0.0% 0.0% 350 0.0% 0.0% 298 0.0% 0.0%
2023.03 2022/05/12 当初予 4,328 - - - 373 - - - 350 - - - 298 - - -
2022.03 2022/05/12 3,204 0.0% +0.1% 351 +3.8% +132.5% 339 +0.6% +173.4% 334 -1.5% +215.1%
2022.03 2022/04/15 修正予 3,204 -2.3% +0.1% 338 +38.0% +123.8% 337 +47.8% +171.8% 339 +77.5% +219.8%
2022.03 2022/02/10 Q3予 3,278 0.0% +2.4% 245 0.0% +62.3% 228 0.0% +83.9% 191 0.0% +80.2%
2022.03 2022/01/27 修正予 3,278 0.0% +2.4% 245 +7.5% +62.3% 228 +16.9% +83.9% 191 +19.4% +80.2%
2022.03 2021/11/11 Q2予 3,278 0.0% +2.4% 228 0.0% +51.0% 195 0.0% +57.3% 160 0.0% +50.9%
2022.03 2021/10/27 修正予 3,278 +2.4% +2.4% 228 +51.0% +51.0% 195 +57.3% +57.3% 160 +50.9% +50.9%
2022.03 2021/08/05 Q1予 3,200 0.0% 0.0% 151 0.0% 0.0% 124 0.0% 0.0% 106 0.0% 0.0%
2022.03 2021/05/13 当初予 3,200 - - - 151 - - - 124 - - - 106 - - -
2021.03 2021/05/13 2,929 0.0% -9.9% 205 +169.7% +169.7% 177 0.0% +268.8% 232 0.0% +510.5%
2021.03 2021/05/10 修正予 2,929 -9.9% -9.9% - - - - 177 +268.8% +268.8% 232 +510.5% +510.5%
2021.03 2021/02/10 Q3予 3,250 0.0% 0.0% 76 0.0% 0.0% 48 0.0% 0.0% 38 0.0% 0.0%
2021.03 2020/11/06 Q2予 3,250 0.0% 0.0% 76 0.0% 0.0% 48 0.0% 0.0% 38 0.0% 0.0%
2021.03 2020/08/06 Q1予 3,250 0.0% 0.0% 76 0.0% 0.0% 48 0.0% 0.0% 38 0.0% 0.0%
2021.03 2020/05/13 当初予 3,250 - - - 76 - - - 48 - - - 38 - - -
2020.03 2020/05/13 2,862 -4.5% -4.5% 61 -41.3% -41.3% 30 -60.0% -60.0% 36 -42.9% -42.9%
2020.03 2020/02/13 Q3予 2,996 0.0% 0.0% 104 0.0% 0.0% 75 0.0% 0.0% 63 0.0% 0.0%
2020.03 2019/11/13 Q2予 2,996 0.0% 0.0% 104 0.0% 0.0% 75 0.0% 0.0% 63 0.0% 0.0%
2020.03 2019/08/09 Q1予 2,996 0.0% 0.0% 104 0.0% 0.0% 75 0.0% 0.0% 63 0.0% 0.0%
2020.03 2019/05/14 当初予 2,996 - - - 104 - - - 75 - - - 63 - - -
2019.03 2019/05/14 2,585 -6.9% -6.9% 93 -21.2% -20.5% 60 -24.1% -23.1% 56 -16.4% -15.2%
2019.03 2019/02/13 Q3予 2,778 0.0% 0.0% 118 0.0% +0.9% 79 0.0% +1.3% 67 0.0% +1.5%
2019.03 2018/11/12 Q2予 2,778 0.0% 0.0% 118 0.0% +0.9% 79 0.0% +1.3% 67 0.0% +1.5%
2019.03 2018/08/10 Q1予 2,778 0.0% 0.0% 118 +0.9% +0.9% 79 +1.3% +1.3% 67 +1.5% +1.5%
2019.03 2018/05/14 当初予 2,778 - - - 117 - - - 78 - - - 66 - - -
2018.03 2018/05/14 2,425 +5.4% +5.4% 196 +148.1% +148.1% 156 +1460.0% +1460.0% 141 +2250.0% +2250.0%
2018.03 2018/02/13 Q3予 2,300 0.0% 0.0% 79 0.0% 0.0% 10 0.0% 0.0% 6 0.0% 0.0%
2018.03 2017/11/13 Q2予 2,300 0.0% 0.0% 79 0.0% 0.0% 10 0.0% 0.0% 6 0.0% 0.0%
2018.03 2017/08/10 Q1予 2,300 - - - 79 - - - 10 - - - 6 - - -
2017.03 2017/05/12 修正予 2,295 -2.0% -2.0% 56 +19.1% +19.1% 23 +155.6% +155.6% 31 - -
2017.03 2017/02/14 Q3予 2,342 0.0% 0.0% 47 0.0% 0.0% 9 0.0% 0.0% 0 - -
2017.03 2016/11/14 Q2予 2,342 0.0% 0.0% 47 0.0% 0.0% 9 0.0% 0.0% 0 - -
2017.03 2016/08/12 Q1予 2,342 - - - 47 - - - 9 - - - 0 - - -
2016.03 2016/05/13 修正予 2,116 +0.3% -5.1% -207 +38.0% -592.9% -230 +35.6% -1869.2% -1,204 -57.4% -17300.0%
2016.03 2016/02/12 Q3予 2,110 0.0% -5.4% -334 0.0% -895.2% -357 0.0% -2846.2% -765 0.0% -11028.6%
2016.03 2015/11/13 Q2予 2,110 0.0% -5.4% -334 0.0% -895.2% -357 0.0% -2846.2% -765 0.0% -11028.6%
2016.03 2015/11/02 修正予 2,110 -5.4% -5.4% -334 -895.2% -895.2% -357 -2846.2% -2846.2% -765 -11028.6% -11028.6%
2016.03 2015/08/14 Q1予 2,230 0.0% 0.0% 42 - - - 13 0.0% 0.0% 7 0.0% 0.0%
2016.03 2015/05/15 当初予 2,230 - - - - - - - 13 - - - 7 - - -
2015.03 2015/05/15 - - - - - - - - - - - - - - - -
2015.03 2015/02/10 Q3予 3,000 0.0% 0.0% 83 0.0% 0.0% 50 0.0% 0.0% 28 0.0% 0.0%
2015.03 2014/11/11 Q2予 3,000 0.0% 0.0% 83 0.0% 0.0% 50 0.0% 0.0% 28 0.0% 0.0%
2015.03 2014/08/12 Q1予 3,000 0.0% 0.0% 83 0.0% 0.0% 50 0.0% 0.0% 28 0.0% 0.0%
2015.03 2014/05/13 当初予 3,000 - - - 83 - - - 50 - - - 28 - - -
2014.03 2014/05/13 2,778 0.0% 0.0% 66 0.0% 0.0% 49 0.0% 0.0% 70 0.0% 0.0%
2014.03 2014/05/07 当初予 2,778 - - - 66 - - - 49 - - - 70 - - -
ページトップへ戻る